Literature DB >> 1079201

Serologic evidence for cross-reacting antigens in two carcinogen-induced murine sarcomas.

D Fritze, D H Kern, S R Waldman, Y H Pilch.   

Abstract

Serological evidence is presented that two chemically-induced (by methylcholanthrene and 3,4-benz(a)pyrene) sarcomas of C3HF mice contain cross-reacting tumor-associated cell-surface antigens. Xenogeneic and syngeneic antitumor antisera against the two sarcomas were studied with an isotopic, complement-dependent, antibody-mediated microcytotoxicity assay and an isotopic antiglobulin test for the detection of antibodies to tumor-associated antigens, in vitro. Absorportions with various tissues were performed which consistently revealed that the specific activity of the antitumor antisera could be removed by absorption with cells from either chemically-induced tumor, while absorption with syngeneic normal adult tissues, normal fetal tissues, or cells from a histogenetically unrelated tumor (spontaneous mammary carcinoma) failed to remove any specific activity. In view of the individual character of carcinogen-induced tumor antigens as detected by tumor transplantation techniques, our results suggest that chemically-induced murine sarcomas (even when induced by different carcinogens) contain both private and common cell-surface antigens, the latter detectable by serological methods. These common tumor-associated antigens may be related to a viral genome involved in the nalignant transformation of carcinogen-induced marine sarcomas.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1079201     DOI: 10.1002/ijc.2910150114

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  2 in total

Review 1.  Transfer of tumor specific immunity with "immune" RNA: prospects for the treatment of human cancer.

Authors:  D Fritze; D H Kern; Y H Pilch
Journal:  Klin Wochenschr       Date:  1976-09-15

2.  Lack of correlation between in vivo rejection of syngeneic fibrosarcomas and in vitro non-specific macrophage cytotoxicity.

Authors:  R Evans; C G Booth; F Spencer
Journal:  Br J Cancer       Date:  1978-11       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.